Delivery Order SPE2DB20D2104-SPE2DB25FMCPD

Award Date 11/21/24
Potential Completion Date 11/22/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The $35,119.82 firm fixed-price delivery order has a period of performance through November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,681.42 firm fixed-price delivery order is for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen, with an ultimate completion date of November 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,081.35 Firm Fixed Price Delivery Order covers the supply of the medication Mounjaro (Tirzepatide) 10 mg/0.5 ml pen in a 0.5 ml quantity. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,035.35, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The contract is a Firm Fixed Price, non-set-aside award with a completion date of June 4, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The contract is a Delivery Order valued at $1,895.56 for the supply of the prescription drug Mounjaro (tirzepatide) 10 mg/0.5 mL pen. The contract has an ultimate completion date of May 17, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The $45,378.33 firm fixed-price contract has an ultimate completion date of October 24, 2024. AmerisourceBergen, a for-profit corporate entity registered in the System for Award Management (SAM.gov), has an extensive history of federal contract awards with DLA and other agencies,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,678.51, is for the delivery of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract was awarded on May 23, 2024 and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,119.35 delivery order contract is for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 ml pens. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 ml pen. The $3,156 firm fixed-price delivery order has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products...
This federal contract award from the Defense Logistics Agency (DLA) was issued to the pharmaceutical distribution company Amerisourcebergen Drug Corp (Amerisourcebergen) to provide the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. The $1,841.00 firm-fixed-price delivery order has an ultimate completion date of August 20, 2024. Amerisourcebergen is the prime contractor for this contract, which does not have a set-aside designation. This award is likely part of a larger Indefinite Delivery...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMCPD
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under contract SPE2DB20D2104|SPE2DB25FMCPD. The $1,533.35 firm fixed-price delivery order is for the supply of the medication Mounjaro (tirzepatide) 5 mg/0.5 mL pens to support federal healthcare programs. The contract has an ultimate completion date of November 22, 2024.

Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. This delivery order is part of that larger contract. The award does not include any set-aside designation, indicating open competition.

Generated 2/27/25, 10:28 AM